Rg5 improved inflammatory skin disorders, such as oxazolone-induced chronic dermatitis in mice, by modulating IL-1β and TNF-α production in macrophage cells and IFN-γ from Th cells [18]. This evidence concerns the gene TNF and inflammatory skin disease.